Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial
Go back to Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial| Edwards Lifesciences (NYSE: EW) | Delayed: 91.26 -0.34 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.60 | 52 Week High | $166.87 | |||
| Open | $90.84 | 52 Week Low | $72.20 | |||
| Day High | $91.58 | P/E | 26.53 | |||
| Day Low | $90.62 | EPS | $3.44 | |||
| Volume | 217,164 | |||||
